Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

BACKGROUND: Endostar is a new endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate whether thoracic perfusion of Endostar could be used to control malignant pleural effusions (MPE). METHODS: We searched the databases of MEDLINE, Web of Science, EMBASE, G...

Descripción completa

Detalles Bibliográficos
Autores principales: Biaoxue, Rong, Xiguang, Cai, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109813/
https://www.ncbi.nlm.nih.gov/pubmed/27842514
http://dx.doi.org/10.1186/s12885-016-2935-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109813/
https://www.ncbi.nlm.nih.gov/pubmed/27842514
http://dx.doi.org/10.1186/s12885-016-2935-4

Ejemplares similares